PharmaVoice Logo

Healthcare Leaders Hub

Top 20 Generic Companies of 2026 

PharmaShots

Top 20 Generic Companies of 2026 

Shots:   20. Alkem  Generic Segment Revenue: $1.64B   Founded Year: 1973   Market Cap: $6.67B   Total Employees: 19,300   Headquarters: Maharashtra, India   Stock Exchange: NSE  19. Towa Pharmaceutical Co  Generic Segment Revenue: $1.72B   Founded Year: 1951   Market Cap: $1.22B   Total Employees: 4,900   Headquarters: Osaka, Japan  Stock Exchange: TYO  18. Amneal  Generic Segment Revenue: $1.74B   Founded Year: 2002   Market Cap: $6.02B   Total Employees: 8,700   Headquarters: New Jersey, United States  Stock Exchange: NASDAQ  17. Stada  Generic Segment… The post Top 20 Generic Companies of 2026  appeared first on PharmaShots.

Read Full Article
Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Pharma Tech

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.

Read Full Article
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma

Pharma Tech

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma

The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma.

Read Full Article
Xanadu and University of Alberta to develop quantum algorithms for cancer

Pharma Tech

Xanadu and University of Alberta to develop quantum algorithms for cancer

Xanadu Quantum Technologies and the University of Alberta in Canada partnered to advance algorithms to treat cancer.

Read Full Article
Why India’s medicines need integrated authentication, enforceable standards

Express Pharma

Why India’s medicines need integrated authentication, enforceable standards

Triggered by recent high profile operations involving counterfeit semaglutide in the domestic markets and anti-rabies vaccines exported to various countries, India’s regulators are plugging the gaps by expanding the existing QR code mandate and may next require online registration of manufacturers and suppliers of printed pharma packaging materials. However, Ankit Gupta, President, ASPA explains to Viveka Rychowdhury, that as counterfeiters evolve, isolated security measures should be replaced with integrated authentication ecosystems and enforceable standards The post Why India’s medicines need integrated authentication, enforceable standards appeared first on Express Pharma.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Aug 14, 2026, 1:30 PM

Top 20 Generic Companies of 2026 

Shots:   20. Alkem  Generic Segment Revenue: $1.64B   Founded Year: 1973   Market Cap: $6.67B   Total Employees: 19,300   Headquarters: Maharashtra, India   Stock Exchange: NSE  19. Towa Pharmaceutical Co  Generic Segment Revenue: $1.72B   Founded Year: 1951   Market Cap: $1.22B   Total Employees: 4,900   Headquarters: Osaka, Japan  Stock Exchange: TYO  18. Amneal  Generic Segment Revenue: $1.74B   Founded Year: 2002   Market Cap: $6.02B   Total Employees: 8,700   Headquarters: New Jersey, United States  Stock Exchange: NASDAQ  17. Stada  Generic Segment… The post Top 20 Generic Companies of 2026  appeared first on PharmaShots.

PharmaShots

Aug 14, 2026, 12:30 PM

Rigel Reports Availability of Veppanu for ER+/HER2-, ESR1-Mutated Breast Cancer

Shots: Ref: PRnewswire  |  Image: Rigel  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Rigel Reports Availability of Veppanu for ER+/HER2-, ESR1-Mutated Breast Cancer appeared first on PharmaShots.

PharmaShots

Aug 14, 2026, 11:30 AM

ArkBio’s Ziresovir Secures the US FDA Approval for P-II Trial in RSV Infant Patients

Shots: Ref: PRnewswire  |  Image: ArkBio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post ArkBio’s Ziresovir Secures the US FDA Approval for P-II Trial in RSV Infant Patients appeared first on PharmaShots.

PharmaShots

Aug 14, 2026, 10:30 AM

Zoetis’ Simparica Trio Receives FDA’s EUA for Treating New World Screwworm Infestations in Dogs and Puppies

Shots: Ref: Businesswire  |  Image: Zoetis  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Zoetis’ Simparica Trio Receives FDA’s EUA for Treating New World Screwworm Infestations in Dogs and Puppies appeared first on PharmaShots.

ET Pharma

Aug 14, 2026, 10:10 AM

Humana agrees not to reference Teva's Israel ties at US drug trial

Humana disclosed its agreement with Teva in a ​Wednesday night filing in the federal court in Philadelphia, where Teva and several other major pharmaceutical ​companies are due to stand trial next month on claims they conspired to inflate the prices of some generic drugs.

Pharma Tech

Aug 14, 2026, 10:08 AM

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.

News

Latest industry coverage

Google News

Aug 14, 2026, 5:03 PM

Inside Disney’s advertising appeal to pharma brands - Medical Marketing and Media

Inside Disney’s advertising appeal to pharma brands  Medical Marketing and Media

Google News

Aug 14, 2026, 5:00 PM

Biotech VCs have become like bankers and we might all pay the price - Financial Times

Biotech VCs have become like bankers and we might all pay the price  Financial Times

Google News

Aug 14, 2026, 4:58 PM

Formation Bio has appointed Michael Ellers as Chief Scientific Officer - UA.NEWS

Formation Bio has appointed Michael Ellers as Chief Scientific Officer  UA.NEWS

Google News

Aug 14, 2026, 4:50 PM

PharmTech Weekly Roundup—August 14, 2026 - PharmTech.com

PharmTech Weekly Roundup—August 14, 2026  PharmTech.com

Google News

Aug 14, 2026, 4:49 PM

2026 Pharm Exec Top 50 Companies - Pharmaceutical Executive

2026 Pharm Exec Top 50 Companies  Pharmaceutical Executive

Google News

Aug 14, 2026, 4:23 PM

Court rules companies can't import Gilead medications from overseas in blow to AFP health programs - CNBC

Court rules companies can't import Gilead medications from overseas in blow to AFP health programs  CNBC

Google News

Aug 14, 2026, 4:21 PM

Up and down the ladder: The latest comings and goings - STAT

Up and down the ladder: The latest comings and goings  STAT

Google News

Aug 14, 2026, 4:03 PM

Supply Chain Signal: Three Tariff Deadlines Reshaping Pharma Manufacturing - Pharmaceutical Commerce

Supply Chain Signal: Three Tariff Deadlines Reshaping Pharma Manufacturing  Pharmaceutical Commerce

Google News

Aug 14, 2026, 4:00 PM

The great MMR divide - Politico

The great MMR divide  Politico

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer